Q9UBF8 (PI4KB_HUMAN) Homo sapiens (Human)
Phosphatidylinositol 4-kinase beta UniProtKBInterProSTRINGInteractive Modelling
Available Structures
20 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS |
Heteromer P62491; | 100.0 | 1×093; 1×GSP; 1×MG; | |||
| PI4KB in complex with Rab11 and the MI359 Inhibitor |
Heteromer P62491; | 100.0 | 1×5W7; 1×GSP; | |||
| PI4KB in complex with Rab11 and the MI364 Inhibitor |
Heteromer P62491; | 100.0 | 1×5W3; 1×GSP; | |||
| PI4KB in complex with Rab11 and the MI356 Inhibitor |
Heteromer P62491; | 100.0 | 1×5W9; 1×GSP; | |||
| PI4KB in complex with Rab11 and the MI369 Inhibitor |
Heteromer P62491; | 100.0 | 1×5W8; 1×GSP; | |||
| PI4KB in complex with Rab11 and the MI358 Inhibitor |
Heteromer P62491; | 100.0 | 1×5W6; 1×GDP; | |||
| Phosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding do… |
Heteromer O75154; P62491; | 100.0 | 4×093; 4×GSP; 4×MG; | |||
| GI targeted CpPI4K inhibitor |
Heteromer P62491; | 100.0 | 1×A1ADE; 1×SO4; 1×GDP; | |||
| Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta in complex w… |
Heteromer P62491; | 100.0 | 2×SO4; 1×GSP; 1×MG; | |||
| Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with the inh… |
Heteromer P62491; | 100.0 | 1×MG; 1×GDP; 2×SO4; 1×BQR; | |||
| Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with a poten… |
Heteromer P62491; | 100.0 | 1×GDP; 2×SO4; 1×5S8; | |||
| Solution structure of the ACBD3:PI4KB complex |
Heteromer Q9H3P7; | 100 | ||||
| Crystal structure of human 14-3-3 zeta in complex with PI4KIIIB peptide |
Heteromer P63104; | 100 | ||||
| Lt 14-3-3 in complex with PI4KIIIB peptide |
Heteromer C5DN49; | 100 | ||||
| Phosphatidylinositol 4-kinase III beta crystallized with ATP | monomer | 100.0 | 1×ATP; | |||
| Phosphatidylinositol 4-kinase III beta crystallized with MI103 inhibitor | monomer | 100.0 | 1×3K7; | |||
| HUMAN PI4KIIIB IN COMPLEX WITH COVALENTLY BOUND INHIBITOR (COMPOUND 8) | monomer | 100 | 1×KIH; 1×MG; 3×EDO; | |||
| HUMAN PI4KIIIB IN COMPLEX WITH COVALENTLY BOUND INHIBITOR (COMPOUND 11) | monomer | 100 | 1×MG; 1×KI7; 1×EDO; | |||
| HUMAN PI4KIIIB IN COMPLEX WITH COVALENTLY BOUND INHIBITOR (COMPOUND 4) | monomer | 100.0 | 1×KHR; 1×MG; 7×EDO; 1×GOL; | |||
| Crystal structure of human Phosphatidylinositol 4-kinase III beta (PI4KIIIbeta) in complex with lig… | monomer | 100.0 | 1×EMW; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4d0l.3.A | monomer | 0.69 | 1×093; | 98.23 | ||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 4d0l.3.A | monomer | 0.71 | 1×093; | 99.29 | ||
| Isoform 3 | 8q6f.1.A | monomer | 0.73 | 1×KHR; 1×MG; | 98.48 | ||